GASTROCURE 10CAP

Each hard gelatin capsule Gastrocure contains: Lansoprazole pellets 352.943 mg ( equivalent to Lansoprazole 30 mg ).

33.60 EGP

Purchase this product now and earn 34 Points!

GASTROCURE 10CAP; lansoprazole, gastrointestinal agents .

ACTIVE-INGREDIENT OF GASTROCURE 10CAP

Each hard gelatin capsule Gastrocure contains: Lansoprazole pellets 352.943 mg ( equivalent to Lansoprazole 30 mg ).

INDICATION OF GASTROCURE 10CAP

Treatment of duodenal and gastric ulcer. Treatment of reflux oesophagitis. Prophylaxis of reflux oesophagitis. eradication of Helicobacter pylori ( H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H. pylori – associated ulcers. Treatment of NSAID-associated benigen gastric ulcers and duodenal ulcers in patients requiring continued NSAID treatment . prophylaxis of NSAID-associated benigen gastric ulcers and duodenal ulcers in patients at risk requiring continued therapy. Symptomatic gastroesophageal reflux disease. Zollinger-Ellison syndrome.

DOSAGE OF GASTROCURE 10CAP

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

Treatment of duodenal ulcers: The recommended dose is 30 once daily for two weeks. in patients not fully healed within this time, the medication is continued at the same dose for another two weeks. Treatment of gastric ulcers: The recommended dose is 30 mg once daily for 4 weeks. The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication may be continued at the same dose for another4 weeks. reflux oesophagitis: The recommended dose is 30 once daily for 4 weeks. in patients not fully healed within this time, the treatment may be continued at the same dose for another 4 weeks. Prophylaxis of reflux oesophagitis: 15 mg once daily. The dose may be increased up to 30 mg daily as necessary. eradication of Helicobacter pylori : When selecting appropriate combination therapy consideration should be given to official local guidance regarding bacterial resistence, duration of treatment, ( most commonly 7 days but sometimes up to 14 days), and appropriate use od antibacterial agents. The recommended dose is 30 mg of lansoprazole twice daily for 7 days in combination with one of the following: clarithromycin 250-500 mg twice daily + amoxicillin 1 gtwice daily. clarithromycin 250 mgtwice daily + metronidazole 400-500 mg twice daily. H. pylori eradication rates of up to 90% , are obtained when calrithromycin is combined with lansoprazole and amoxicillin or metronidazole. Six months after successful eradication treatment, the risk of re-infection is low and relapse is therefore unlikely. Use of regimen including lansoprazole 30 mg twice daily, amoxicillin 1 g twice daily and metronidazole 400-500 mg twice daily has also benn examined. Lower eradication rates were seen using this combination than in regimens involving clarithromycin. It may be suitable for those who are unable to take clarithromycin as part of an eradication therapy, when local resistence rates to metronidazole are low. Treatment of NSAID-associated benigen gastric and duodenal ulcers in patients requiring continued NSAID treatment: 30 once daily for four weeks. in patients not fully healed within this time, the treatment may be continued at the same dose for another four weeks. For patients at risk or with ulcers that are difficult to heal, a longer course of treatment and/or a higher dose should probably be used. Prohylaxis of NSAID associated gastric and duodenal ulcers in patients at risk ( such as age > 65 or history of gastric or duodenal ulcer) requiring prolonged NSAID treatment: 15 mg once daily. If the treatment fails the dose 30 mg once daily should be used. Symptomatic gastroesophageal reflux disease: The recommended dose is 15 mg or 30 mg daily. Relief of symptoms is obtained rapidly. Individual adjustment of dosage should be considered. If the symptoms are not relieved within 4 weeks with a daily dose of 30 mg, further examinations are recommended. Zollinger-Ellison syndrome: The recommended initial dose is 60 mg once daily. The dose should be individually adjusted and the treatment should be continued for as long as necessary. Daily doses of up to 180 mg have been used. If the required daily dose exceeds 120 mg, it should be given in two divided doses. Impaired hepatic and renal function: There is no need for a dose adjustment in patients with impaired renal function. Patients with moderate or severe liver disease should be kept under regular supervision and a 50 % reduction of the daily dose is recommended. Elderly: Due to reduced clearsnce of lansoprazole in the elderly an adjustment of dose may be necessary based on individual requirements. A daily dose of 30 mg should not be exceeded in the elderly unless there are compelling clinical indications. Paediatric population: The use of lansoprazole is not recommended in children as clinical data are limited. Treatment of small children below one year of age should be avoided as available data have not shown beneficial effects in the treatment of gastro-oesophageal reflux disease.

OVER-DOSAGE OF GASTROCURE 10CAP

The effects of overdose on lansoprazole in humans are not known ( although the acute toxicity is likely to be low) and consequently , instruction for treatment cannot be given . However, daily doses of up to 180 mg of lansoprazole orally and up to 90 mg of lansoprazole intravenously have been administered in trials without significant undesirable effects. In case of suspected overdose the patient should be monitored. Lansoprazole is not sinificantly eliminated by haemodialysis. If necessary, gastric emptying, charcoal and symptomatic therapy is recommended.

CONTRA-INDICATION OF GASTROCURE 10CAP

Hypersensitivity to the active substance or to any of the excipients. Gastrocure should not be administered with atazanavir.

STORAGE OF GASTROCURE 10CAP

Store at temperature not exceeding 30°C, in a dry place.
PACK OF GASTROCURE 10CAP
Carton box containing ( AL/opaque PVC) strip of 10 hard gelatin capsules and an inner leaflet.
GASTROCURE 10CAP MANUFACTURED BY
Alfacure Pharmaceuticals Badr City, Cairo, Egypt.

https://www.nhs.uk/medicines/lansoprazole/

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

1 review for GASTROCURE 10CAP

  1. karim (verified owner)

    Excellent for stomach

Add a review

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top